Previous 10 | Next 10 |
2024-05-03 14:37:00 ET Summary Zoetis is a leader in animal health, focusing on R&D to develop innovative medicines and technologies for pets and livestock. Concerns have arisen about the safety of their drugs, but Zoetis appears confident and reported impressive revenue growt...
2024-05-03 13:49:33 ET Summary The SPDR S&P 500 ETF Trust had a 4.03% loss in April, slightly outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares, -4.13%. The top 15 dividend growth stocks for May 2024 offer an average dividend yield of 1.23% and appear to be ...
2024-05-03 09:00:23 ET Image source: The Motley Fool. Zoetis (NYSE: ZTS) Q1 2024 Earnings Call May 02, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Zoetis (ZTS) Q1 2024 Earnings Call Transcript
2024-05-02 16:56:00 ET Investors were meowing for animal healthcare specialist Zoetis (NYSE: ZTS) on Thursday, following the company's release of its latest quarterly results. These obviously pleased market participants, as the stock's price leaped nearly 6% higher over the course o...
2024-05-02 13:25:26 ET Zoetis Inc (ZTS) Q1 2024 Results Conference Call May 02, 2024 08:30 AM ET Company Participants Steve Frank - Vice President of Investor Relations Kristin Peck - Chief Executive Officer Wetteny Joseph - Chief Financial Officer Conferen...
2024-05-02 11:40:03 ET More on Zoetis Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment Zoetis: My Favorite Healthcare Stock Right Now Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness Zoetis Non-GAAP EPS of $1.38 beats by $0.04,...
2024-05-02 07:04:10 ET More on Zoetis Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment Zoetis: My Favorite Healthcare Stock Right Now Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness Zoetis Q1 2024 Earnings Preview Zoet...
2024-05-02 07:00:00 ET Summary Value investors have been frustrated as growth stocks have outperformed for the past 15 years. Value investing is a long-term strategy that requires patience and a focus on fundamentals. Three blue-chip stocks, Bristol-Myers, Zoetis, and Monster ...
Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 Delivers 12% Operational Growth in Revenue and 15% Operational Growth in Adjusted Net Income for First ...
2024-05-01 16:36:45 ET Summary Phibro Animal Health has seen lackluster performance over the past decade, seeing modest sales growth and declining margins. The company recently announced a significant deal with Zoetis, acquiring their medicated feed additive product portfolio for ...
News, Short Squeeze, Breakout and More Instantly...
Zoetis Inc. Class A Company Name:
ZTS Stock Symbol:
NYSE Market:
2024-05-30 08:15:00 ET Since its spinoff from Pfizer in 2013, animal healthcare behemoth Zoetis (NYSE: ZTS) has seen its cash from operations nearly quintuple as a stand-alone company. Powered by a diverse array of animal health offerings that serve both the companion an...
SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman is urging investors who suffered substantial losses in Zoetis Inc. (NYSE: ZTS) to promptly report their losses here . Additionally, individuals with relevant knowledge who may assist in the investigation are encouraged to conta...
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the third quarter of 2024. The dividend will be paid on Wednesday, September 4, 2024, to all holders of record of the Company’s common stock as of the close of business on Thursday, July 18...